PROSolventum Corp
stock86.30
+0.99 (+1.16%)
Price as of 13 Oct, 20:32 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Neutral
Mixed investment profile
Technical Analysis
Short-Term Outlook
Neutral
2 bull · 2 bear · 1 neutral
Medium-Term Outlook
Bearish
1 bull · 3 bear · 0 neutral
Price below 50-day MA
Price above 200-day MA
Price below 12-day EMA
Price below 26-day EMA
Neutral momentum zone
MACD below signal line
Oversold — potential reversal up
Price near lower band — potential bounce
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+0.99
Market Cap
14080836000
Exchange
NYSE
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Solventum Corp
What is Solventum Corp?
Solventum is a healthcare company that was spun off from 3M in 2024, specializing in medical technologies like wound care, health information systems, and surgical supplies. It operates by providing essential medical devices and data solutions that help clinicians improve patient outcomes across hospitals and clinics worldwide.
Is Solventum Corp a good investment?
On the positive side, Solventum holds a strong market position in established healthcare segments, but investors must weigh this against the challenges of operating as a newly independent company with significant debt obligations. Market performance remains speculative as the company builds its own track record outside of its former parent, so please remember that this summary is for educational purposes and not financial advice.
How do you invest in Solventum Corp?
You can invest in Solventum by purchasing shares through a regulated brokerage account using the ticker symbol SOLV. Many investors also gain exposure to the stock by holding healthcare-focused index funds or ETFs that include Solventum within their portfolios.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for SOLV — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 12 Oct 2026Targets
Famous Investors Holding SOLV
Ray Dalio
177.9K sh · 0.1% of portfolio
$13.73M
NEW
Ken Griffin
93.6K sh · 0.0% of portfolio
$7.22M
NEW
Ken Griffin
63.5K sh · 0.0% of portfolio
$4.90M
NEW
Ken Griffin
34.7K sh · 0.0% of portfolio
$2.68M
NEW
Mario Gabelli
11.7K sh · 0.0% of portfolio
$903.3K
NEW
Ken Griffin
3.4K sh · 0.0% of portfolio
$262.3K
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.